Carvedilol increases the systemic bioavailability of oral digoxin.
- 1 April 1990
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 29 (4) , 486-490
- https://doi.org/10.1111/j.1365-2125.1990.tb03668.x
Abstract
The effects of a single oral dose of 25 mg carvedilol on the plasma and urinary kinetics of digoxin after an oral and intravenous 0.5 mg dose, were investigated in two separate double‐blind, placebo‐controlled, period‐balanced cross‐over studies in healthy male subjects. Carvedilol increased the mean maximum plasma concentration and the area under the plasma concentration time‐curve of digoxin when administered orally. The effects were virtually confined to the first 4 h after dosing, and the apparent terminal disposition rate constant was not changed. Carvedilol did not alter the plasma and urinary kinetics of intravenously administered digoxin.Keywords
This publication has 10 references indexed in Scilit:
- Pharmacokinetic Interactions with DigoxinClinical Pharmacokinetics, 1988
- Pharmacological Profile of Carvedilol as a β-Blocking Agent with Vasodilating and Hypotensive PropertiesJournal of Cardiovascular Pharmacology, 1987
- A simple BASIC program for the calculation of nonparametric confidence intervals in bioequivalence testingComputer Methods and Programs in Biomedicine, 1987
- Clinical pharmacology of carvedilol in normal volunteersClinical Pharmacology & Therapeutics, 1987
- Generalization of distribution – Free confidence intervals for bioavailability ratiosEuropean Journal of Clinical Pharmacology, 1985
- A Simple Method for Evaluating the Shapiro-Francia W' Test of Non-NormalityJournal of the Royal Statistical Society: Series D (The Statistician), 1983
- Peak Plasma Digoxin Concentration and CardiotoxicityPublished by Springer Nature ,1978
- PLASMA-DIGOXIN CONCENTRATIONS AFTER AN INTRAVENOUS LOADING DOSEThe Lancet, 1974